News
Press Releases
2021/11/15
WuXi ATU Opens New Facility in Philadelphia, Tripling Testing Capacity to Support Global Customers
November 15, 2021 – Philadelphia. WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the official opening of its advanced therapies testing facility at 400 Rouse Boulevard in Philadelphia’s Navy Yard.
Read more2021/10/29
WuXi AppTec Reports Strong Third-Quarter 2021 Results
Revenue Up 30.6% Year-Over-Year to RMB5,985 Million Net Profit Attributable to Owners of the Company Up 36.2% Year-Over-Year to RMB887 Million Diluted EPS Up 30.4% Year-Over-Year to RMB0.30 Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 37.8% Year-Over-Year to RMB1,358 Million Adjusted Non-IFRS Diluted EPS Up 39.4% Year-Over-Year to RMB0.46
Read more2021/10/18
WuXi ATU Opens New Manufacturing Facility to Further Enhance Its CTDMO Services for Global Customers
Philadelphia, 17 October 2021 - WuXi Advanced Therapies Inc. (WuXi ATU) – a wholly owned subsidiary of WuXi AppTec – today announced the opening of its new process development and commercial manufacturing facility in Lin-gang, Shanghai. WuXi ATU is a leading Contract, Testing, Development and Manufacturing Organization (CTDMO) headquartered in Philadelphia. As its fourth manufacturing site worldwide, the new facility will supplement WuXi ATU’s global footprint and will further join with other sites in the United States, United Kingdom and China to enable global customers with enhanced capacity and efficient services.
Read more2021/09/05
WuXi AppTec Receives AA ESG Rating from MSCI
Shanghai, September 5, 2021 – WuXi AppTec (“the Company”) is pleased to announce that Morgan Stanley Capital International ("MSCI”) has upgraded its MSCI ESG Rating to AA. The Company also received outstanding scores in the areas of “corporate governance” and “product safety and quality”. This new rating reflects WuXi AppTec’s commitment to incorporating environmental and social responsibilities into the company’s business strategies and operations.
Read more2021/08/12
WuXi AppTec Reports Strong 2021 Interim Results
Revenue Up 45.7% Year-Over-Year to RMB10,537 Million Net Profit Attributable to Owners of the Company Up 55.8% Year-Over-Year to RMB2,675 Million Diluted EPS Up 46.8% Year-Over-Year to RMB0.91 Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 67.8% Year-Over-Year to RMB2,448 Million Adjusted Non-IFRS Diluted EPS Up 58.5% Year-Over-Year to RMB0.84
Read more